[Biological studies during Bouillaud's disease; clinical, hematological, electrophoretic and serological (antistreptolysin O) findings during its evolution].

J. Chaptal,R. Jean,C. Campo,D. Alram,J. Fraisse

Abstract:

What problem does this paper attempt to address?

Investigation of immunosuppressive properties of inactivated human immunodeficiency virus and possible neutralization of this effect by some patient sera.

Bo Hofmann,E. Langhoff,Bjarne Ørskov Lindhardt,Niels Odum,J. J. HYLDIG-NIELSEN,L. P. Ryder,Per Platz,Bodil K. Jakobsen,K. Bendtzen,Niels Jacobsen,Brian Lerche,Claus Schafer-Nielsen,Ebbe Dickmeiss,Kay Ulrich,Arne Svejgaard

DOI: https://doi.org/10.1016/0008-8749(89)90032-4

IF: 4.178

1989-07-01

Cellular Immunology

Abstract:
Interactions between sleep disturbances and Alzheimer's disease on brain function: a preliminary study combining the static and dynamic functional MRI.

Kaicheng Li,Xiao Luo,Qingze Zeng,Yerfan Jiaerken,Shuyue Wang,Xiaopei Xu,Xiaojun Xu,Jingjing Xu,Chao Wang,Jiong Zhou,Peiyu Huang,Minming Zhang

DOI: https://doi.org/10.1038/s41598-019-55452-9

IF: 4.6

2019-01-01

Scientific Reports

Abstract:Though sleep disturbance constitutes the risk factor for Alzheimer's disease (AD), the underlying mechanism is still unclear. This study aims to explore the interaction between sleep disturbances and AD on brain function. We included 192 normal controls, 111 mild cognitive impairment (MCI), and 30 AD patients, with either poor or normal sleep (PS, NS, respectively). To explore the strength and stability of brain activity, we used static amplitude of low-frequency fluctuation (sALFF) and dynamic ALFF (dALFF) variance. Further, we examined white matter hyperintensities (WMH) and amyloid PET deposition, representing the vascular risk factor and AD-related hallmark, respectively. We observed that sleep disturbance significantly interacted with disease severity, exposing distinct effects on sALFF and dALFF variance. Interestingly, PS groups showed the dALFF variance trajectory of initially increased, then decreased and finally increased along the AD spectrum, while showing the opposite trajectory of sALFF. Further correlation analysis showed that the WMH burden correlates with dALFF variance in PS groups. Conclusively, our study suggested that sleep disturbance interacts with AD severity, expressing as effects of compensatory in MCI and de-compensatory in AD, respectively. Further, vascular impairment might act as important pathogenesis underlying the interaction effect between sleep and AD.
The regulation of the pentose phosphate cycle in rat liver.

H. Krebs,L. Eggleston

DOI: https://doi.org/10.1016/0065-2571(74)90025-9

Advances in Enzyme Regulation

Abstract:
Sleep disorders and risk of alzheimer's disease: A two-way road

Rafael Antônio Vicente Lacerda,Janaína Aparecida Favero Desio,Camila Marciele Kammers,Silvana Henkes,Monique Freitas de Sá,Everton Ferreira de Souza,Driele Martins da Silva,Camilla Teixeira Pinheiro Gusmão,Júlio César Claudino Dos Santos

DOI: https://doi.org/10.1016/j.arr.2024.102514

Abstract:Substantial sleep impairment in patients with Alzheimer's disease (AD) is one of the emerging points for continued efforts to better understand the disease. Individuals without cognitive decline, an important marker of the clinical phase of AD, may show early alterations in the sleep-wake cycle. The objective of this critical narrative review is to explore the bidirectional pathophysiological correlation between sleep disturbances and Alzheimer's Disease. Specifically, it examines how the disruption of sleep homeostasis in individuals without dementia could contribute to the pathogenesis of AD, and conversely, how neurodegeneration in individuals with Alzheimer's Disease might lead to dysregulation of the sleep-wake cycle. Recent scientific results indicate that sleep disturbances, particularly those related to impaired glymphatic clearance, may act as an important mechanism associated with the genesis of Alzheimer's Disease. Additionally, amyloid deposition and tau protein hyperphosphorylation, along with astrocytic hyperactivation, appear to trigger changes in neurotransmission dynamics in areas related to sleep, which may explain the onset of sleep disturbances in individuals with AD. Disruption of sleep homeostasis appears to be a modifiable risk factor in Alzheimer's disease. Whenever possible, the use of non-pharmacological strategies becomes important in this context. From a different perspective, additional research is needed to understand and treat the dysfunction of the sleep-wake cycle in individuals already affected by AD. Early recognition and correction of sleep disturbances in this population could potentially mitigate the progression of dementia and improve the quality of life for those with AD.
1031 Association Between Objective Sleep Architecture and Biomarkers of Alzheimer's Disease

Jiong Chen,Clemence Cavailles,Jiangli Jin,Laura Stankeviciute,Song Gao,Dantao Peng,Yue Leng

DOI: https://doi.org/10.1093/sleep/zsae067.01031

IF: 6.313

2024-04-20

SLEEP

Abstract:Abstract Introduction Growing evidence suggests a bi-directional association between sleep and Alzheimer’s disease (AD), with several studies showing an association between self-reported sleep disturbances and AD biomarkers. However, the association between polysomnography (PSG)-assessed sleep architecture and AD biomarkers remains unknown. We aim to investigate the associations between sleep architecture features and AD biomarkers in a clinical population with and without cognitive impairment. Methods We examined 128 participants [mean age of 70.9 years (±9.7), 43.8% of men] from an outpatient memory clinic, of whom 23 were healthy controls, 41 patients with mild cognitive impairment, and 64 patients with AD. Sleep architecture features were derived from PSG data and categorized by tertiles. Four AD biomarkers were measured, including tau-181, Brain-Derived Neurotrophic Factor (BDNF), and neurofilament light (NFL) obtained from blood samples, along with Aβ levels measured from amyloid positron emission tomography scans. Multivariable linear regressions models were performed to assess the associations between sleep architecture features and AD biomarkers. Results After adjustment for age, gender, APOE4 status, diabetes mellitus, smoking habits, and body mass index, participants in the highest REM latency tertile (i.e., with longer REM latency; >192.7 minutes) were associated with increased levels of tau-181 (β= 0.25, 95% confidence interval (CI)= 0.01;0.55) and Aβ (β= 0.15, 95% CI= 0.06;0.26), and with decreased level of BDNF (β= -0.51, 95% CI= -0.70;-0.20) compared to participants in the lowest tertile (i.e., with shorter REM latency; < 98.2 minutes). Moreover, being in the middle SWS percentage tertile (i.e., SWS percentage between 2.5 and 10.2) was associated with a lower level of tau-181 (β= -0.18, 95% CI= -0.34;-0.02) compared to being in the lowest tertile (i.e., shorter SWS percentage; < 2.5)). We did not find any association between AD biomarkers and sleep duration, efficiency, latency, or other sleep architecture features. Conclusion In this cross-sectional study of a clinical population, we highlight the importance of REM latency, and to a lesser extent, SWS percentage, in relation to AD biomarkers. Future research is needed to examine the longitudinal association between sleep architecture and AD biomarkers and clarify underlying mechanisms. Support (if any)

neurosciences,clinical neurology
Associations between self-reported sleep patterns and health, cognition and amyloid measures: results from the Wisconsin Registry for Alzheimer's Prevention

Lianlian Du,Rebecca Langhough,Bruce P Hermann,Erin Jonaitis,Tobey J Betthauser,Karly Alex Cody,Kimberly Mueller,Megan Zuelsdorff,Nathaniel Chin,Gilda E Ennis,Barbara B Bendlin,Carey E Gleason,Bradley T Christian,David T Plante,Rick Chappell,Sterling C Johnson

DOI: https://doi.org/10.1093/braincomms/fcad039

2023-02-24

Abstract:Previous studies suggest associations between self-reported sleep problems and poorer health, cognition, Alzheimer's disease pathology and dementia-related outcomes. It is important to develop a deeper understanding of the relationship between these complications and sleep disturbance, a modifiable risk factor, in late midlife, a time when Alzheimer's disease pathology may be accruing. The objectives of this study included application of unsupervised machine learning procedures to identify distinct subgroups of persons with problematic sleep and the association of these subgroups with concurrent measures of mental and physical health, cognition and PET-identified amyloid. Dementia-free participants from the Wisconsin Registry for Alzheimer's Prevention (n = 619) completed sleep questionnaires including the Insomnia Severity Index, Epworth Sleepiness Scale and Medical Outcomes Study Sleep Scale. K-means clustering analysis identified discrete sleep problem groups who were then compared across concurrent health outcomes (e.g. depression, self-rated health and insulin resistance), cognitive composite indices including episodic memory and executive function and, in a subset, Pittsburgh Compound B PET imaging to assess amyloid burden. Significant omnibus tests (P < 0.05) were followed with pairwise comparisons. Mean (SD) sample baseline sleep assessment age was 62.6 (6.7). Cluster analysis identified three groups: healthy sleepers [n = 262 (42.3%)], intermediate sleepers [n = 229 (37.0%)] and poor sleepers [n = 128 (20.7%)]. All omnibus tests comparing demographics and health measures across sleep groups were significant except for age, sex and apolipoprotein E e4 carriers; the poor sleepers group was worse than one or both of the other groups on all other measures, including measures of depression, self-reported health and memory complaints. The poor sleepers group had higher average body mass index, waist-hip ratio and homeostatic model assessment of insulin resistance. After adjusting for covariates, the poor sleepers group also performed worse on all concurrent cognitive composites except working memory. There were no differences between sleep groups on PET-based measures of amyloid. Sensitivity analyses indicated that while different clustering approaches resulted in different group assignments for some (predominantly the intermediate group), between-group patterns in outcomes were consistent. In conclusion, distinct sleep characteristics groups were identified with a sizable minority (20.7%) exhibiting poor sleep characteristics, and this group also exhibited the poorest concurrent mental and physical health and cognition, indicating substantial multi-morbidity; sleep group was not associated with amyloid PET estimates. Precision-based management of sleep and related factors may provide an opportunity for early intervention that could serve to delay or prevent clinical impairment.
1008 Daytime Sleepiness Is Associated with Increased Cerebrospinal Fluid Tau Proteins in Alzheimer’s Disease

Cynthia Okamoto,Lorena Sordo,Ariel Neikrug,Joshua Grill,Elizabeth Head,Ruth Benca,David Sultzer,Bryce Mander

DOI: https://doi.org/10.1093/sleep/zsae067.01008

IF: 6.313

2024-04-20

SLEEP

Abstract:Abstract Introduction Sleep disturbance increases Alzheimer’s disease (AD) biomarkers, but it remains unclear whether the magnitiude of this effect differs by cognitive status. Addressing this unknown will elucidate when it is most critical to intervene to moderate AD pathophysiology and slow or arrest clinical progression. Methods A total of 155 participants, enrolled in Alzheimer Disease Research Center studies at University of California, Irvine (mean age 72.34 ± 7.07 years, 60.0% female) completed subjective assessment of sleep and cerebrospinal fluid (CSF) collection. Participants were divided into four cognitive status groups (Cognitively Normal, n=89; Questionable Cognitive Impairment, n=19; Mild Cognitive Impairment, n=33; and mild to moderately severe AD dementia, n=14). The Medical Outcomes Study Sleep Scale (MOS-SS) subscales assessed multiple sleep domains: Sleep Disturbance, Sleep Adequacy, Sleep Somnolence, Sleep Problems Index I, and Sleep Problems Index II. CSF biomarkers included β-amyloid 42 (Aβ42), total tau (t-tau), and phosphorylated tau (p-tau181). Moderation by cognitive status on the relationships among sleep scores and CSF biomarkers was assessed using the PROCESS macro in SPSS, adjusting for age and sex. Moderation by sleep scores in the cognitive status-CSF biomarkers relationship was also tested. Results After adjusting for age and sex, moderation analyses revealed significant interactions between sleep somnolence and cognitive status on CSF t-tau (F=3.3, p=0.023) and p-tau181 (F=2.9, p=0.035) but not Aβ42 (F=0.057, p=0.98) protein levels. The associations between sleep somnolence and t-tau (B = 4.18, SE = 1.51, t = 2.76, p = 0.01) and p-tau181 (B = 0.50, SE = 0.18, t = 2.69, p = 0.01) were positive and stronger in the AD group in comparison to all other cognitive status groups (all p>0.35). Conclusion These findings indicate that in AD patients, greater subjective daytime sleepiness is associated with higher levels of t-tau and p-tau181 protein levels. As tau proteins are associated with neurodegeneration and cognitive decline, daytime sleepiness, whether or not due to the presence of sleep disorders such as sleep apnea, may be a risk factor or indicator of symptomatic progression of dementia in AD. Future studies should explore the efficacy of sleep-based interventions in slowing AD dementia progression. Support (if any) NIH K01AG068353, NIH T35AG076424, ADRC P30AG066519

neurosciences,clinical neurology
Impaired 24-h activity patterns are associated with an increased risk of Alzheimer's disease, Parkinson's disease, and cognitive decline

Joseph R. Winer,Renske Lok,Lara Weed,Zihuai He,Kathleen L. Poston,Elizabeth C. Mormino,Jamie M. Zeitzer

DOI: https://doi.org/10.1186/s13195-024-01411-0

2024-02-15

Alzheimer s Research & Therapy

Abstract:Sleep-wake regulating circuits are affected during prodromal stages in the pathological progression of both Alzheimer's disease (AD) and Parkinson's disease (PD), and this disturbance can be measured passively using wearable devices. Our objective was to determine whether accelerometer-based measures of 24-h activity are associated with subsequent development of AD, PD, and cognitive decline.

neurosciences,clinical neurology
0740 Does XX or XY Mark the Spot: Sex-specific Analysis of Polysomnographic Sleep and Cognition in Older Adults

Ashley Curtis,Amy Costa,Madison Musich,Chloe Rzeppa,Christina McCrae

DOI: https://doi.org/10.1093/sleep/zsae067.0740

IF: 6.313

2024-04-20

SLEEP

Abstract:Abstract Introduction Poor sleep health is a proposed risk factor for Alzheimer’s disease (AD). Despite known sex differences in AD prevalence (higher in women), whether sex impacts associations between objective sleep parameters and specific cognitive functions remains underexplored. Such investigations are warranted and will provide information regarding potential sex-specific targets for early intervention and/or markers of AD risk. This study tested whether sex moderates associations between polysomnographic assessed sleep and cognition in older adults. Methods Older adults (Mage=68.2±5.5; 44 women/29 men) completed overnight polysomnography (Sleep Profiler) and cognitive tasks [NIH Toolbox: Pattern Comparison (processing speed), Oral Symbol Digit Test (attention and processing speed), List Sorting (working memory), Auditory Verbal Memory Task (episodic memory), Flanker (inhibition), Dimensional Change Card Sort (cognitive flexibility)]. Multiple regressions examined whether sleep metrics (sleep onset latency, wake time after sleep onset, sleep efficiency, total sleep time), macro-architecture (%N1-N3, %REM) or micro-architecture (sleep spindle duration and index) interacted with biological sex in associations with cognition, controlling for age, education and apnea-hypopnea index. Results Sleep onset latency (R-squared=.06, p=.03) and sleep spindle duration (R-squared=.05, p=.05) interacted with sex in their associations with cognitive flexibility. Specifically, in women (not men), longer sleep onset latency (B=-.01, SE=.002, p=.03) and longer spindle duration (B=-.08, SE=.03, p = .005) were associated with worse cognitive flexibility. Conclusion The link between polysomnographic sleep and cognitive flexibility in older adults may be sex dependent. Sleep onset latency cognitive (rumination/worry) and neural (physiological arousal/pre-frontal activation) mechanisms may interact with female sex-steroid alterations (post-menopausal drops in circulating estrogen and progesterone) and exacerbate its negative impact on cognitive flexibility. We also speculate that longer sleep spindle duration in the presence of dysfunctional cognitive flexibility may reflect compensatory thalamo-prefrontal cortical regulation (greater need for nighttime cognitive/cortical arousal reduction) that is further influenced by prefrontal sex-steroid mechanisms. Longitudinal studies in larger samples of cognitively healthy and impaired older adults are needed to further understand whether polysomnographic sleep metrics represent sex-specific markers of future cognitive decline. Support (if any) This research was made possible by awards (PI:Curtis) from the American Academy of Sleep Medicine Foundation, a foundation of the American Academy of Sleep Medicine.

neurosciences,clinical neurology
Amyloid beta-independent sleep markers associated with early regional tau burden and cortical thinning

Laura Stankeviciute,Jasmeer P Chhatwal,Raina Levin,Valentina Pinilla,Aaron P Schultz,Susan Redline,Keith A Johnson,Reisa A Sperling,Nataliia Kozhemiako,Shaun Purcell,Ina Djonlagic

DOI: https://doi.org/10.1002/dad2.12616

2024-07-29

Abstract:Introduction: Sleep is crucial for memory consolidation and the clearance of toxic proteins associated with Alzheimer's disease (AD). We examined the association between sleep characteristics and imaging biomarkers of early amyloid beta (Aβ) and tau pathology as well as neurodegeneration in brain regions known to be affected in the incipient stages of AD. Methods: Thirty-nine cognitively unimpaired (CU) participants of the Harvard Aging Brain Study underwent at-home polysomnography as well as tau positron emission tomography (flortaucipir-PET), amyloid PET (Pittsburgh compound B [PiB]-PET), and magnetic resonance imaging-derived assessment of cortical thickness (CT). Results: Increased N1 sleep was associated with a higher tau PET signal (β = 0.009, p = 0.001) and lower CT in the temporal composite region of interest (β = -0.017, p = 0.007). Decreased slow-wave sleep (SWS) was associated with higher tau burden in the temporal composite (β = -0.008, p = 0.005) and lower CT (β = 0.008, p = 0.002), even after controlling for global PiB-PET. Discussion: In CU older adults, lower SWS and higher N1 sleep were associated with higher tau burden and lower CT in brain regions associated with early tau deposition and vulnerable to AD-related neurodegeneration through mechanisms dissociable from amyloid deposition. Highlights: We report the results of an observational study, which leveraged -a well-characterized cohort of healthy aging (Harvard Aging Brain Study) by adding in-home full polysomnograms.By adding at-home polysomnograms to this unique and deeply phenotyped cohort, we examined variations in sleep architecture that are associated with Alzheimer's disease (AD) pathologic changes.Our results confirmed the association of sleep changes with early tau and cortical neurodegenerative changes that were independent of amyloid.The results will be of importance in monitoring sleep-related variations in relation to the natural history of AD pathology and in designing sleep-focused clinical trials.
Upper limb reinnervation in C6 tetraplegia using a triple nerve transfer: case report.

Natasha van Zyl,Jodie Hahn,C. Cooper,Michael D Weymouth,S. Flood,M. Galea

DOI: https://doi.org/10.1016/j.jhsa.2014.06.017

2014-09-01

Abstract:
Sleep in Alzheimer’s disease: a systematic review and meta-analysis of polysomnographic findings

Ye Zhang,Rong Ren,Linghui Yang,Haipeng Zhang,Yuan Shi,Hamid R. Okhravi,Michael V. Vitiello,Larry D. Sanford,Xiangdong Tang

DOI: https://doi.org/10.1038/s41398-022-01897-y

2022-04-01

Translational Psychiatry

Abstract:Abstract Polysomnography (PSG) studies of sleep changes in Alzheimer’s disease (AD) have reported but not fully established the relationship between sleep disturbances and AD. To better detail this relationship, we conducted a systematic review and meta-analysis of reported PSG differences between AD patients and healthy controls. An electronic literature search was conducted in EMBASE, MEDLINE, All EBM databases, CINAHL, and PsycINFO inception to Mar 2021. Twenty-eight studies were identified for systematic review, 24 of which were used for meta-analysis. Meta-analyses revealed significant reductions in total sleep time, sleep efficiency, and percentage of slow-wave sleep (SWS) and rapid eye movement (REM) sleep, and increases in sleep latency, wake time after sleep onset, number of awakenings, and REM latency in AD compared to controls. Importantly, both decreased SWS and REM were significantly associated with the severity of cognitive impairment in AD patients. Alterations in electroencephalogram (EEG) frequency components and sleep spindles were also observed in AD, although the supporting evidence for these changes was limited. Sleep in AD is compromised with increased measures of wake and decreased TST, SWS, and REM sleep relative to controls. AD-related reductions in SWS and REM sleep correlate with the degree of cognitive impairment. Alterations in sleep EEG frequency components such as sleep spindles may be possible biomarkers with relevance for diagnosing AD although their sensitivity and specificity remain to be clearly delineated. AD-related sleep changes are potential targets for early therapeutic intervention aimed at improving sleep and slowing cognitive decline.

psychiatry
Which Are the Most Reliable Sleep Parameters that Predict Cognitive Decline and Alzheimer's Disease?

Luigi Ferini-Strambi

DOI: https://doi.org/10.3233/jad-231311

2024-02-07

Journal of Alzheimer s Disease

Abstract:Sleep disorders can represent an independent risk factor for cognitive decline and Alzheimer's disease (AD). It remains to be clarified if specific sleep parameters could be considered biomarkers of AD-related neurodegeneration. Several studies solely investigated the results of cross-sectional research, without providing conclusive evidence. Few longitudinal studies showed some inconsistencies in macrostructural and microstructural sleep findings. Methodological heterogeneity among studies can explain the discrepancies in the results. Moreover, the polysomnographic findings are usually related to only one-night recording. The combination of actigraphic recordings with sleep EEG monitoring for some consecutive days should be considered in future research.

neurosciences
Pump and probe spectroscopy with continuous wave quantum cascade lasers.

J. Kirkbride,Sarah K Causier,Andrew R Dalton,D. Weidmann,G. Ritchie

DOI: https://doi.org/10.1063/1.4864001

2014-02-06

Abstract:This paper details infra-red pump and probe studies on nitric oxide conducted with two continuous wave quantum cascade lasers both operating around 5 μm. The pump laser prepares a velocity selected population in a chosen rotational quantum state of the v = 1 level which is subsequently probed using a second laser tuned to a rotational transition within the v = 2 ← v = 1 hot band. The rapid frequency scan of the probe (with respect to the molecular collision rate) in combination with the velocity selective pumping allows observation of marked rapid passage signatures in the transient absorption profiles from the polarized vibrationally excited sample. These coherent transient signals are influenced by the underlying hyperfine structure of the pump and probe transitions, the sample pressure, and the coherent properties of the lasers. Pulsed pump and probe studies show that the transient absorption signals decay within 1 μs at 50 mTorr total pressure, reflecting both the polarization and population dephasing times of the vibrationally excited sample. The experimental observations are supported by simulation based upon solving the optical Bloch equations for a two level system.
Sleep, Cognitive impairment, and Alzheimer’s disease: A Systematic Review and Meta-Analysis

Omonigho M. Bubu,Michael Brannick,James Mortimer,Ogie Umasabor-Bubu,Yuri V. Sebastião,Yi Wen,Skai Schwartz,Amy R. Borenstein,Yougui Wu,David Morgan,William M. Anderson

DOI: https://doi.org/10.1093/sleep/zsw032

IF: 6.313

2016-12-09

SLEEP

Abstract:Study Objectives: Mounting evidence implicates disturbed sleep or lack of sleep as one of the risk factors for Alzheimer's disease (AD), but the extent of the risk is uncertain. We conducted a broad systematic review and meta-analysis to quantify the effect of sleep problems/disorders on cognitive impairment and AD.Methods: Original published literature assessing any association of sleep problems or disorders with cognitive impairment or AD was identified by searching PubMed, Embase, Web of Science, and the Cochrane library. Effect estimates of individual studies were pooled and relative risks (RR) and 95% confidence intervals (CI) were calculated using random effects models. We also estimated the population attributable risk.Results: Twenty-seven observational studies (n = 69216 participants) that provided 52 RR estimates were included in the meta-analysis. Individuals with sleep problems had a 1.55 (95% CI: 1.25-1.93), 1.65 (95% CI: 1.45-1.86), and 3.78 (95% CI: 2.27-6.30) times higher risk of AD, cognitive impairment, and preclinical AD than individuals without sleep problems, respectively. The overall meta-analysis revealed that individuals with sleep problems had a 1.68 (95% CI: 1.51-1.87) times higher risk for the combined outcome of cognitive impairment and/or AD. Approximately 15% of AD in the population may be attributed to sleep problems.Conclusion: This meta-analysis confirmed the association between sleep and cognitive impairment or AD and, for the first time, consolidated the evidence to provide an "average" magnitude of effect. As sleep problems are of a growing concern in the population, these findings are of interest for potential prevention of AD.

neurosciences,clinical neurology
Sleep dysregulation, memory impairment, and CSF biomarkers during different levels of neurocognitive functioning in Alzheimer’s disease course

Claudio Liguori,Fabio Placidi,Francesca Izzi,Matteo Spanetta,Nicola Biagio Mercuri,Alessandra Di Pucchio

DOI: https://doi.org/10.1186/s13195-019-0571-3

2020-01-04

Alzheimer's Research and Therapy

Abstract:Abstract Background Alzheimer's disease (AD) is frequently accompanied by sleep impairment, which can induce AD-related neurodegeneration. We herein investigated the sleep architecture, cognition, and cerebrospinal fluid (CSF) biomarkers (tau proteins and β-amyloid 42 ) during AD progression from subjective cognitive impairment (SCI) to mild cognitive impairment (MCI) and eventually to AD dementia, and compared the results with cognitively normal (CN) subjects. Methods We included patients affected by SCI, MCI, mild AD, and moderate-to-severe AD in our study along with CN subjects as controls. All the subjects underwent nocturnal polysomnography to investigate sleep, neuropsychological testing to evaluate cognition, and lumbar puncture for CSF AD biomarkers assessment. Results Sleep (both rapid eye movement (REM) and non-REM sleep) and memory function are both progressively impaired during the course of AD from SCI to mild and subsequently to moderate AD. Further, sleep dysregulation appears earlier than cognitive deterioration, with a reduction of CSF β-amyloid 42 level. Conclusion Sleep, memory, and CSF AD biomarkers are closely interrelated in AD progression from the earliest asymptomatic and preclinical stages of the disease related in AD since the earliest and preclinical stages of the disease.
Sleep disturbances, cognitive decline, and AD biomarkers alterations in early Parkinson's disease

Rui Zhong,Caiting Gan,Huimin Sun,Kezhong Zhang

DOI: https://doi.org/10.1002/acn3.52089

IF: 5.43

2024-05-21

Annals of Clinical and Translational Neurology

Abstract:Objective We aimed to investigate whether each type of sleep disturbances (i.e., pRBD, EDS, and insomnia) is specifically associated with faster decline in global cognition and different cognitive domains among de novo PD patients. We also assessed the influence of sleep disturbances on core AD CSF biomarkers alterations and conversion to dementia. Methods Prospectively longitudinal data were obtained from the PPMI cohort. Sleep disturbances and cognition ability were assessed by questionnaires at baseline and follow‐up visits. Generalized linear mixed models were utilized to assess the effect of sleep disturbances on cognitive decline and core AD CSF biomarkers change. The associations between sleep disturbances and conversion to dementia were analyzed using Cox regression analysis. Results Baseline pRBD was associated with faster decline in global cognition and all cognitive domains, including verbal episodic memory, visuospatial ability, executive function, language, and processing speed. EDS was associated with faster decline in three cognitive domains, including verbal episodic memory, executive function/working memory, and processing speed. Insomnia was associated with faster decline in global cognition and verbal episodic memory. Meanwhile, pRBD and EDS were associated with longitudinal decrease of CSF Aβ42. Baseline pRBD increased the risk of conversion to dementia. The risk of dementia in PD patients with multiple sleep disturbances also increased compared with those without sleep disturbance. Interpretation Sleep disturbances (i.e., pRBD, EDS, and insomnia) were associated with cognitive decline in early PD. EDS and pRBD were associated with decrease of CSF Aβ42. Moreover, pRBD was associated with conversion to dementia.

neurosciences,clinical neurology
0224 Sleep Deprivation and Recovery Sleep Impact Serum Biomarkers of Alzheimer's Disease in Retired Adults

Matthew Lehrer,Xuemei Zeng,Robert Krafty,Kristine Wilkens,Daniel Buysse,Thomas Karikari

DOI: https://doi.org/10.1093/sleep/zsae067.0224

IF: 6.313

2024-04-20

SLEEP

Abstract:Abstract Introduction Short sleep increases Alzheimer’s disease (AD) risk, and sleep facilitates clearance of AD-related metabolites. Blood-based AD biomarkers (e.g., beta amyloid [Aβ] 42/40 ratio, phosphorylated tau181 [p-Tau181], neurofilament light chain [NfL], glial fibrillary acidic protein [GFAP]) are validated and increasingly used clinically. However, the impact of sleep deprivation and recovery sleep on these markers is unclear. This study determined the effects of sleep deprivation and recovery sleep on serum AD biomarkers in retired adults and explored: 1) whether changes in EEG slow-wave activity (SWA) from baseline to recovery sleep were associated with serum AD biomarker changes, and 2) whether findings differed between retired night shift and day workers. Methods Participants were 58 cognitively normal retired shift workers (n = 28) and retired day workers (n = 30). All completed a 60-hour laboratory study including a baseline night of EEG sleep recording, one night of total sleep deprivation, and one night of recovery sleep. EEG SWA (0.5-1Hz) was assessed during baseline and recovery sleep. Blood was collected the morning after each night. Serum samples were analyzed for Aβ40, Aβ42, p-Tau181, NfL, and GFAP using ultra-sensitive immunoassay. Linear mixed models determined the effects of sleep deprivation and recovery sleep on biomarker levels adjusted for age, sex, race/ethnicity, and education. Results Mean participant age was 67.8 +/- 5.5 years, 52% were female, 86% were White, and mean education was 16.0 +/- 1.9 years. Serum Aβ42/40 ratio, NfL, and GFAP decreased following one night of sleep deprivation. Following recovery sleep, the Aβ42/40 ratio remained below baseline, while NfL and GFAP increased to baseline levels. Serum pTau-181 did not change following sleep deprivation or recovery sleep. Greater SWA increase from baseline to recovery sleep was associated with smaller Aβ42/40 ratio decrease. Findings did not differ between shift and day work groups. Conclusion In retired adults, acute sleep deprivation and recovery sleep impacted serum AD biomarker levels. Sleep characteristics may therefore affect the diagnostic accuracy of these tests. Former night shift work exposure did not influence serum biomarker responses, suggesting no effect of long-term shift work exposure over time. SWA may aid Aβ clearance during sleep. Support (if any) K01AG075171, R01AG047139, R01GM140476, R01GM113243

neurosciences,clinical neurology
Sleep Characteristics in Older Adults with Different Levels of Risk for Dementia: A Cross-sectional Study

Xiuxiu Huang,Shifang Zhang,Yuxi Fang,Xiaoyan Zhao,Ting Cao,Yongan Sun,Qiaoqin Wan

DOI: https://doi.org/10.2174/1567205020666230303110244

2022-01-01

Current Alzheimer Research

Abstract:Background Sleep problems are very prevalent in older adults, especially in those at risk for dementia. But the relationships between sleep parameters and subjective or objective cognitive decline are still inconclusive. Aim The study aimed to investigate the self-reported and objectively measured sleep characteristics in older adults with mild cognitive impairment (MCI) and subjective cognitive decline (SCD). Methods This study adopted a cross-sectional design. We included older adults with SCD or MCI. Sleep quality was measured separately by the Pittsburgh sleep quality index (PSQI) and ActiGraph. Participants with SCD were divided into low, moderate, and high levels of SCD groups. Independent samples T-tests, one-way ANOVA, or nonparametric tests were used to compare the sleep parameters across groups. Covariance analyses were also performed to control the covariates. Results Around half of the participants (45.9%) reported poor sleep quality (PSQI<7), and 71.3% of participants slept less than 7 hours per night, as measured by ActiGraph. Participants with MCI showed shorter time in bed (TIB) (p<0.05), a tendency of shorter total sleep time (TST) at night (p = 0.074) and for each 24-hour cycle (p = 0.069), compared to those with SCD. The high SCD group reported the highest PSQI total score and longest sleep latency than all the other three groups (p<0.05). Both the MCI and high SCD groups had shorter TIB and TST for each 24-hour cycle than the low or moderate SCD groups. Besides, participants with multiple-domain SCD reported poorer sleep quality than those with single-domain SCD (p<0.05). Conclusion Sleep dysregulation is prevalent in older adults with a risk for dementia. Our findings revealed that objectively measured sleep duration might be an early sign of MCI. Individuals with high levels of SCD demonstrated poorer self-perceived sleep quality and deserved more attention. Improving sleep quality might be a potential target to prevent cognitive decline for people with a risk for dementia.
Self-reported sleep and β-amyloid deposition in community-dwelling older adults.

D. Wong,L. Ferrucci,S. Resnick,Mark N. Wu,Yun Zhou,M. Bilgel,A. Spira,Y. An,E. Simonsick,Alyssa A. Gamaldo

DOI: https://doi.org/10.1001/jamaneurol.2013.4258

IF: 29.907

2013-12-01

JAMA Neurology

Abstract:IMPORTANCE Older adults commonly report disturbed sleep, and recent studies in humans and animals suggest links between sleep and Alzheimer disease biomarkers. Studies are needed that evaluate whether sleep variables are associated with neuroimaging evidence of β-amyloid (Aβ) deposition. OBJECTIVE To determine the association between self-reported sleep variables and Aβ deposition in community-dwelling older adults. DESIGN, SETTING, AND PARTICIPANTS Cross-sectional study of 70 adults (mean age, 76 [range, 53-91] years) from the neuroimaging substudy of the Baltimore Longitudinal Study of Aging, a normative aging study. EXPOSURE Self-reported sleep variables. MAIN OUTCOMES AND MEASURES β-Amyloid burden, measured by carbon 11-labeled Pittsburgh compound B positron emission tomography distribution volume ratios (DVRs). RESULTS After adjustment for potential confounders, reports of shorter sleep duration were associated with greater Aβ burden, measured by mean cortical DVR (B = 0.08 [95% CI, 0.03-0.14]; P = .005) and precuneus DVR (B = 0.11 [0.03-0.18]; P = .007). Reports of lower sleep quality were associated with greater Aβ burden measured by precuneus DVR (B = 0.08 [0.01-0.15]; P = .03). CONCLUSIONS AND RELEVANCE Among community-dwelling older adults, reports of shorter sleep duration and poorer sleep quality are associated with greater Aβ burden. Additional studies with objective sleep measures are needed to determine whether sleep disturbance causes or accelerates Alzheimer disease.

Medicine,Psychology

[Biological studies during Bouillaud's disease; clinical, hematological, electrophoretic and serological (antistreptolysin O) findings during its evolution].

Investigation of immunosuppressive properties of inactivated human immunodeficiency virus and possible neutralization of this effect by some patient sera.

Interactions between sleep disturbances and Alzheimer's disease on brain function: a preliminary study combining the static and dynamic functional MRI.

The regulation of the pentose phosphate cycle in rat liver.

Sleep disorders and risk of alzheimer's disease: A two-way road

1031 Association Between Objective Sleep Architecture and Biomarkers of Alzheimer's Disease

Associations between self-reported sleep patterns and health, cognition and amyloid measures: results from the Wisconsin Registry for Alzheimer's Prevention

1008 Daytime Sleepiness Is Associated with Increased Cerebrospinal Fluid Tau Proteins in Alzheimer’s Disease

Impaired 24-h activity patterns are associated with an increased risk of Alzheimer's disease, Parkinson's disease, and cognitive decline

0740 Does XX or XY Mark the Spot: Sex-specific Analysis of Polysomnographic Sleep and Cognition in Older Adults

Amyloid beta-independent sleep markers associated with early regional tau burden and cortical thinning

Upper limb reinnervation in C6 tetraplegia using a triple nerve transfer: case report.

Sleep in Alzheimer’s disease: a systematic review and meta-analysis of polysomnographic findings

Which Are the Most Reliable Sleep Parameters that Predict Cognitive Decline and Alzheimer's Disease?

Pump and probe spectroscopy with continuous wave quantum cascade lasers.

Sleep, Cognitive impairment, and Alzheimer’s disease: A Systematic Review and Meta-Analysis

Sleep dysregulation, memory impairment, and CSF biomarkers during different levels of neurocognitive functioning in Alzheimer’s disease course

Sleep disturbances, cognitive decline, and AD biomarkers alterations in early Parkinson's disease

0224 Sleep Deprivation and Recovery Sleep Impact Serum Biomarkers of Alzheimer's Disease in Retired Adults

Sleep Characteristics in Older Adults with Different Levels of Risk for Dementia: A Cross-sectional Study

Self-reported sleep and β-amyloid deposition in community-dwelling older adults.